These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 35053997)

  • 61. Microwave ablation versus other interventions for hepatocellular carcinoma: A systematic review and meta-analysis.
    Cui R; Yu J; Kuang M; Duan F; Liang P
    J Cancer Res Ther; 2020; 16(2):379-386. PubMed ID: 32474527
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Comparison of radiofrequency ablation and microwave ablation for benign thyroid nodules: A systematic review and meta-analysis.
    Guo DM; Chen Z; Zhai YX; Su HH
    Clin Endocrinol (Oxf); 2021 Jul; 95(1):187-196. PubMed ID: 33556187
    [TBL] [Abstract][Full Text] [Related]  

  • 63. MWA Versus RFA for Perivascular and Peribiliary CRLM: A Retrospective Patient- and Lesion-Based Analysis of Two Historical Cohorts.
    van Tilborg AA; Scheffer HJ; de Jong MC; Vroomen LG; Nielsen K; van Kuijk C; van den Tol PM; Meijerink MR
    Cardiovasc Intervent Radiol; 2016 Oct; 39(10):1438-46. PubMed ID: 27387188
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The risk factors for long-term survival outcome in solitary hepatocellular carcinoma up to 2 cm: Propensity score matching analysis in a population cohort with a high rate of HBV infection.
    Wang G; Zhang W; Tan Y; Jiang L; Yang J; Yang J; Yan L
    Int J Surg; 2019 Dec; 72():1-6. PubMed ID: 31610283
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Treatment Optimization for Hepatocellular Carcinoma in Elderly Patients in a Japanese Nationwide Cohort.
    Kaibori M; Yoshii K; Hasegawa K; Ogawa A; Kubo S; Tateishi R; Izumi N; Kadoya M; Kudo M; Kumada T; Sakamoto M; Nakashima O; Matsuyama Y; Takayama T; Kokudo N;
    Ann Surg; 2019 Jul; 270(1):121-130. PubMed ID: 29608544
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Radiation Segmentectomy versus TACE Combined with Microwave Ablation for Unresectable Solitary Hepatocellular Carcinoma Up to 3 cm: A Propensity Score Matching Study.
    Biederman DM; Titano JJ; Bishay VL; Durrani RJ; Dayan E; Tabori N; Patel RS; Nowakowski FS; Fischman AM; Kim E
    Radiology; 2017 Jun; 283(3):895-905. PubMed ID: 27930089
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Comparison of NK cell subsets, receptors and functions induced by radiofrequency ablation and microwave ablation in HBV-associated primary hepatocellular carcinoma.
    Wang HY; Cui XW; Zhang YH; Chen Y; Lu NN; Sheng SP; Gao WF; Yang XZ; Duan ZP
    Front Oncol; 2023; 13():1048049. PubMed ID: 37205189
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Percutaneous thermal ablation for primary hepatocellular carcinoma: A systematic review and meta-analysis.
    Chinnaratha MA; Chuang MY; Fraser RJ; Woodman RJ; Wigg AJ
    J Gastroenterol Hepatol; 2016 Feb; 31(2):294-301. PubMed ID: 26114968
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Percutaneous microwave ablation vs radiofrequency ablation in the treatment of hepatocellular carcinoma.
    Poulou LS; Botsa E; Thanou I; Ziakas PD; Thanos L
    World J Hepatol; 2015 May; 7(8):1054-63. PubMed ID: 26052394
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Comparative Efficacy of Microwave versus Radiofrequency Ablation in Hepatocellular Carcinoma: Systematic Review and Meta-Analysis of Randomized-Controlled Trials.
    Rey I; Darmadi D
    Rom J Intern Med; 2024 Jun; ():. PubMed ID: 38905615
    [No Abstract]   [Full Text] [Related]  

  • 71. Safety and Efficacy of Physical Thermal Ablation Combined Sorafenib for Hepatocellular Carcinoma: A Meta-analysis.
    Jin M; Yu Q; Liu Y; Xu W; Fu X; Ji B
    J Clin Transl Hepatol; 2021 Apr; 9(2):149-159. PubMed ID: 34007796
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Factors Associated with Tumor Progression After Percutaneous Ablation of Hepatocellular Carcinoma: Comparison Between Monopolar Radiofrequency and Microwaves. Results of a Propensity Score Matching Analysis.
    Bouda D; Barrau V; Raynaud L; Dioguardi Burgio M; Paulatto L; Roche V; Sibert A; Moussa N; Vilgrain V; Ronot M
    Cardiovasc Intervent Radiol; 2020 Nov; 43(11):1608-1618. PubMed ID: 32533309
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The efficacy of microwave ablation versus liver resection in the treatment of hepatocellular carcinoma and liver metastases: A systematic review and meta-analysis.
    Yang G; Xiong Y; Sun J; Wang G; Li W; Tang T; Li J
    Int J Surg; 2020 May; 77():85-93. PubMed ID: 32173611
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Transarterial Chemoembolization Monotherapy Versus Combined Transarterial Chemoembolization-Microwave Ablation Therapy for Hepatocellular Carcinoma Tumors ≤5 cm: A Propensity Analysis at a Single Center.
    Chen QF; Jia ZY; Yang ZQ; Fan WL; Shi HB
    Cardiovasc Intervent Radiol; 2017 Nov; 40(11):1748-1755. PubMed ID: 28681222
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Microwave ablation versus radiofrequency ablation for primary hyperparathyroidism: a multicenter retrospective study.
    Wei Y; Peng CZ; Wang SR; He JF; Peng LL; Zhao ZL; Cao XJ; Li Y; Chai HH; Yu MA
    Int J Hyperthermia; 2021; 38(1):1023-1030. PubMed ID: 34219596
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Thermal Ablation in the Management of Adrenal Metastasis Originating from Non-small Cell Lung Cancer: A 5-year Single-center Experience.
    Botsa EI; Thanou IL; Papatheodoropoulou AT; Thanos LI
    Chin Med J (Engl); 2017 Sep; 130(17):2027-2032. PubMed ID: 28707652
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Comparison between microwave ablation and bipolar radiofrequency ablation in benign thyroid nodules: differences in energy transmission, duration of application and applied shots.
    Vorländer C; David Kohlhase K; Korkusuz Y; Erbelding C; Luboldt W; Baser I; Korkusuz H
    Int J Hyperthermia; 2018; 35(1):216-225. PubMed ID: 30300014
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Iodized oil computed tomography versus ultrasound-guided radiofrequency ablation for early hepatocellular carcinoma.
    Wu CH; Liang PC; Su TH; Lin MC; Chang YH; Shih TT; Kao JH
    Hepatol Int; 2021 Oct; 15(5):1247-1257. PubMed ID: 34338971
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A Meta-Analysis of Clinical Outcomes After Radiofrequency Ablation and Microwave Ablation for Lung Cancer and Pulmonary Metastases.
    Yuan Z; Wang Y; Zhang J; Zheng J; Li W
    J Am Coll Radiol; 2019 Mar; 16(3):302-314. PubMed ID: 30642784
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Minimally invasive surgery versus radiofrequency ablation for single subcapsular hepatocellular carcinoma ≤ 2 cm with compensated liver cirrhosis.
    Lin CH; Ho CM; Wu CH; Liang PC; Wu YM; Hu RH; Lee PH; Ho MC
    Surg Endosc; 2020 Dec; 34(12):5566-5573. PubMed ID: 31993821
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.